Skip to main content
Clinical Trials/NCT03038464
NCT03038464
Unknown
Not Applicable

Benefit of Synovial Aspiration and Serological Testing in Two-stage Revision Arthroplasty of Prosthetic Joint Infection

Technical University of Munich1 site in 1 country40 target enrollmentNovember 1, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diagnosis Prosthetic Joint Infection
Sponsor
Technical University of Munich
Enrollment
40
Locations
1
Primary Endpoint
Reinfection rate
Last Updated
9 years ago

Overview

Brief Summary

The two-stage protocol is gold standard in terms of infection control treating prosthetic joint infections of total hip and total knee arthroplasty. The antibiotic pause for diagnostic reasons before reconstruction (stage two) is discussed concerning persistence of infection and development of resistant bacterial strains. Serological markers and synovial analysis are common use to exclude persistence of infection.

The investigators therefore asked 1) is the serological testing of c-reactive protein and leukocytes a valuable tool to predict a persistence of infection and 2) what is the role of synovial aspiration of PMMA Spacers on hip and knee joints.

Registry
clinicaltrials.gov
Start Date
November 1, 2016
End Date
May 1, 2019
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Technical University of Munich
Responsible Party
Principal Investigator
Principal Investigator

Harrasser

Principal Investigator

Technical University of Munich

Eligibility Criteria

Inclusion Criteria

  • Patients with periprostheitc joint infection

Exclusion Criteria

  • Reinfection in history

Outcomes

Primary Outcomes

Reinfection rate

Time Frame: 2 years

Reinfection rate after reimplantation of joint prosthesis

Study Sites (1)

Loading locations...

Similar Trials